CPI-613 is a racemic mixture of the enantiomers of a synthetic alpha-lipoic lipoic acid analogue with potential chemopreventive and antineoplastic activities. Although the exact mechanism of action is unknown, alpha-lipoic acid analogue CPI-613 has been shown to inhibit metabolic and regulatory processes required for cell growth in solid tumors. Both enantiomers in the racemic mixture exhibit antineoplastic activity.

prudect name : CPI-613 is a racemic mixture of the enantiomers of a synthetic alpha-lipoic lipoic acid analogue with potential chemopreventive and antineoplastic activities. Although the exact mechanism of action is unknown, alpha-lipoic acid analogue CPI-613 has been shown to inhibit metabolic and regulatory processes required for cell growth in solid tumors. Both enantiomers in the racemic mixture exhibit antineoplastic activity.
CPI-613

Synonyms: 6,8-bis(benzylthio)octanoic acidCAS NO: 95809-78-2Molecular Formula: C₂₂H₂₈O₂S₂Molecular Weight: 388.59Purity: 99% minSolubility: In DMSOStorage: −20°C

BAY 73-4506 References PubMed ID：:http://www.ncbi.nlm.nih.gov/pubmed/18508809